One of the major limitations of our xenograft model is the animal immunodeficiency, which is preventing, on the one hand, analysis of TAT impact on the immune cells that constitutively express PD-L1, and, on the other hand, analysis of endogenous immune response. This evidence concerns the gene CD274 and immunodeficiency disease.